Skip to main content Back to Top
Advertisement

ASHP Supports Addiction and Recovery Act

The support of S.524, the Comprehensive Addiction and Recovery Act of 2016.

March 3, 2016


The Honorable Sheldon Whitehouse
530 Hart Senate Office Building
Washington, DC 20510

The Honorable Amy Klobuchar
302 Hart Senate Office Building
Washington, DC 20510

The Honorable Christopher Coons
127A Russell Senate Office Building
Washington, DC 20510

The Honorable Rob Portman
448 Russell Senate Office Building
Washington, DC 20510

The Honorable Kelly Ayotte
144 Russell Senate Office Building
Washington, DC 20510

The Honorable Mark Kirk
524 Hart Senate Office Building
Washington, DC 20510



Dear Senators Whitehouse, Portman, Klobuchar, Ayotte, Coons, and Kirk:

On behalf of ASHP (American Society of Health-System Pharmacists), I am writing in support of S.524, the Comprehensive Addiction and Recovery Act of 2016. This legislation would provide for additional education, treatment, monitoring, and other resources to address the opioid abuse and heroin epidemic currently facing the nation. ASHP applauds your leadership on this issue.

ASHP is the national professional organization whose more than 43,000 members include pharmacists, pharmacy technicians, and student pharmacists who provide patient care services in hospitals, health systems, and ambulatory clinics. For over 70 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety.

S. 524 is consistent with ASHP’s position that pharmacists can help break the cycle of continuously increased opioid dosing and potency despite decreased pain relief. We advocate for the use of evidence-based guidelines that include parameters for opioid escalation and discontinuation, as well as use of adjuvant medications and non-pharmacologic interventions. We are pleased that the bill includes pharmacists as members of the task force responsible for development of best practices for pain management.

ASHP thanks you for introducing this important legislation, and we look forward to working with you to move the bill forward.

Sincerely,

Kasey K. Thompson, Pharm.D., M.S., M.B.A.
Senior Vice President and Interim Chief Operating Officer
Office of Policy, Planning and Communications